Dr. French will serve as the Northwestern University site PI. Dr. French will lead Aim 3, involving the budget impact analysis, cost effectiveness analysis, and financial sustainability of Cog intervention. Dr. French will work closely with co-investigators Drs. Boustani and Verghese in implementing site data collection to account for and ensure implementation of the economic components that are part of Aim 3. Dr. French will participate in all team meetings, assemble interim NIH reports, and publish and present findings from Aim 3. Dr. French, additionally, will co-author papers from Aims 1 and 2, alongside the project team.
|Effective start/end date
|9/17/22 → 8/31/27
- Albert Einstein College of Medicine (312416 AMD1 // 5U01NS105565-08)
- National Institute of Neurological Disorders and Stroke (312416 AMD1 // 5U01NS105565-08)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.